Leslie Leinwand - MyoKardia Co-Founder
Founder
Leslie Leinwand is Co-Founder of MyoKardia
Phone | 650 741-0900 |
Web | www.myokardia.com |
MyoKardia Management Efficiency
The company has return on total asset (ROA) of (23.07) % which means that it has lost $23.07 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (42.7) %, meaning that it created substantial loss on money invested by shareholders. MyoKardia's management efficiency ratios could be used to measure how well MyoKardia manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 51.61 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. MyoKardia has a current ratio of 17.62, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist MyoKardia until it has trouble settling it off, either with new capital or with free cash flow. So, MyoKardia's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MyoKardia sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MyoKardia to invest in growth at high rates of return. When we think about MyoKardia's use of debt, we should always consider it together with cash and equity.
Similar Executives
Found 1 records | FOUNDER Age | ||
Pr MD | BioNTech SE | 59 |
Management Performance
Return On Equity | -42.7 | |||
Return On Asset | -23.07 |
MyoKardia Leadership Team
Elected by the shareholders, the MyoKardia's board of directors comprises two types of representatives: MyoKardia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MyoKardia. The board's role is to monitor MyoKardia's management team and ensure that shareholders' interests are well served. MyoKardia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MyoKardia's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eric Topol, Independent Director | ||
Sunil Agarwal, Independent Director | ||
Christine MD, Co-Founder | ||
Taylor Harris, CFO | ||
Mark Perry, Independent Director | ||
June Lee, COO | ||
Cynthia Ladd, General Counsel | ||
William Fairey, Executive Vice President and Chief Commercial Officer | ||
Wendy Yarno, Independent Director | ||
Kevin Starr, Director | ||
Jake Bauer, Vice President - Business Development and Business Operations | ||
Joseph Lambing, Senior Vice President - Nonclinical and Pharmaceutical Development | ||
Steven Chan, Vice President Corporate Controller | ||
Mary Cranston, Director | ||
Katherine Bowdish, Director | ||
Robert McDowell, Sr. VP of Drug Discovery | ||
David Meeker, Independent Director | ||
Marc Semigran, Chief Medical Officer | ||
Leslie Leinwand, Co-Founder | ||
Tassos Gianakakos, CEO and President and Director | ||
Charles Homcy, Director | ||
Jonathan Fox, Chief Medical Officer | ||
Kimberly Popovits, Independent Director |
MyoKardia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MyoKardia a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -42.7 | |||
Return On Asset | -23.07 | |||
Current Valuation | 11.15 B | |||
Shares Outstanding | 53.32 M | |||
Shares Owned By Insiders | 2.22 % | |||
Shares Owned By Institutions | 94.59 % | |||
Number Of Shares Shorted | 4.63 M | |||
Price To Earning | (57.57) X | |||
Price To Book | 14.19 X | |||
Price To Sales | 253.61 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in MyoKardia Stock
If you are still planning to invest in MyoKardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyoKardia's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets |